Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

novartis_window

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017 Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …
News
astrazeneca_plaque

AstraZeneca’s Tagrisso beats standard of care in halting NSCLC

September 11, 2017 Research and Development, Sales and Marketing AstraZeneca, ESMO, NSCLC, Tagrisso, non-small cell cell cancer, pharma, pharmaceutical

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …
News
casebia_logo1_rgb

Casebia Therapeutics bolsters leadership by bringing in two new faces

September 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, CRISPR Therapeutics, Casebia Therapeutics, biotech, drugs, pharma, pharmaceutical

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …
Appointment
microscope-275984_960_720

Balancing the R&D equation: Measuring the return from pharmaceutical innovation

September 8, 2017 Medical Communications, Research and Development

Following Deloitte’s anaylsis of the return on R&D spend by biopharmaceutical companies, this report reveals the key difficulties faced, as …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

This week saw a number of hard-hitting stories hit the headlines that are sure to have resonant consequences. Following the …
News
toothbrush

Aspirin may be a cost-effective alternative to fillings

September 8, 2017 Medical Communications, Research and Development aspirin, biotech, dentist, drugs, pharma, pharmaceutical, tooth decay

Researchers from Queen University, Belfast, have discovered that aspirin may be able to reverse the effects of tooth decay. In …
News
bms

BMS’ Opdivo gets a potential first-line boost in kidney cancer

September 8, 2017 Medical Communications, Research and Development Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients …
News
spotleukaemia

Spotting Leukaemia

September 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …
Feature

New ‘pen’ device identifies cancerous tissue in just ten seconds

September 7, 2017 Research and Development Cancer, University of Texas, digital, medicine, pharma, pharmaceutical, tumour

Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous …
News
shutterstock_232245868

Amgen and AstraZeneca’s experimental drug cuts asthma exacerbations by up to 71%

September 7, 2017 Research and Development Amgen, AstraZeneca, MedImmune, asthma, pharma, pharmaceutical, tezepelumab

An anti-TSLP monoclonal antibody jointly developed by Amgen and AstraZeneca’s global biologics and research division, MedImmune, has met its primary …
News
astrazeneca-sign

AstraZeneca’s Brilinta protects against adverse cardiovascular events for up to 5 years, new data reveals

September 7, 2017 Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, pharma, pharmaceutical, ticagrelor, trial

AstraZeneca has revealed new data supporting the long-term use and efficacy of its cardiovascular drug Brilinta (ticagrelor), showing that the …
News

FDA halts trial after first CAR T-associated patient death

September 6, 2017 Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical

French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …
News
novo_flag

Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million

September 6, 2017 Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical

Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …
News

Anti-HIV drug PrEP proves safety in gay and bisexual adolescents

September 6, 2017 Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma

A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …
News
shutterstock_38078521

Real-world data prove efficacy of Eisai and Bial’s epilepsy treatment

September 6, 2017 Research and Development Bial, Eisai, Zebinix, epilepsy, pharma

Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025